Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir Onn

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2018
A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass PathwaysDonatella Romaniello, Luigi Mazzeo, Maicol Mancini, et al.
Radiology|September 27, 2005
Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcomeAmir Onn, Du Hwan Choe, Roy S Herbst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancerAmir Onn, Arlene M Correa, Michael Gilcrease, et al.
Molecular Cancer Therapeutics|February 20, 2007
Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockadeWenjuan Wu, Amir Onn, Takeshi Isobe, et al.
Molecular Cancer Therapeutics|November 24, 2006
Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor-independent urokinase-type plasminogen activator inhibitionSeung-Hyun Oh, Ok-Hee Lee, Claudia P Schroeder, et al.
Frontiers in Oncology|July 5, 2022
Liquid First Is "Solid" in Naïve Non-Small Cell Lung Cancer Patients: Faster Turnaround Time With High Concordance to Solid Next-Generation SequencingOr Sehayek, Waleed Kian, Amir Onn, et al.
Translational Lung Cancer Research|July 18, 2020
Predicting brain metastasis in early stage non-small cell lung cancer patients by gene expression profilingIris Kamer, Yael Steuerman, Inbal Daniel-Meshulam, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 2, 2013
A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot studyEyal Greenberg, Michal J Besser, Eytan Ben-Ami, et al.
Lung|June 27, 2014
EGFR mutation testing practice in advanced non-small cell lung cancerJair Bar, Arnold Cyjon, Dov Flex, et al.
Journal for Immunotherapy of Cancer|May 17, 2022
Soluble HLA peptidome of pleural effusions is a valuable source for tumor antigensSofia Khazan-Kost, Gal Cafri, Dganit Melamed Kadosh, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2018
A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass PathwaysDonatella Romaniello, Luigi Mazzeo, Maicol Mancini, et al.
Radiology|September 27, 2005
Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcomeAmir Onn, Du Hwan Choe, Roy S Herbst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancerAmir Onn, Arlene M Correa, Michael Gilcrease, et al.
Molecular Cancer Therapeutics|February 20, 2007
Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockadeWenjuan Wu, Amir Onn, Takeshi Isobe, et al.
Molecular Cancer Therapeutics|November 24, 2006
Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor-independent urokinase-type plasminogen activator inhibitionSeung-Hyun Oh, Ok-Hee Lee, Claudia P Schroeder, et al.
Frontiers in Oncology|July 5, 2022
Liquid First Is "Solid" in Naïve Non-Small Cell Lung Cancer Patients: Faster Turnaround Time With High Concordance to Solid Next-Generation SequencingOr Sehayek, Waleed Kian, Amir Onn, et al.
Translational Lung Cancer Research|July 18, 2020
Predicting brain metastasis in early stage non-small cell lung cancer patients by gene expression profilingIris Kamer, Yael Steuerman, Inbal Daniel-Meshulam, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 2, 2013
A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot studyEyal Greenberg, Michal J Besser, Eytan Ben-Ami, et al.
Lung|June 27, 2014
EGFR mutation testing practice in advanced non-small cell lung cancerJair Bar, Arnold Cyjon, Dov Flex, et al.
Journal for Immunotherapy of Cancer|May 17, 2022
Soluble HLA peptidome of pleural effusions is a valuable source for tumor antigensSofia Khazan-Kost, Gal Cafri, Dganit Melamed Kadosh, et al.
Pageof 10